"AND Gate" Logic Fluorescence Sensing Platform for Highly Specific Detection of Dual microRNA Biomarkers

Area of Science:

• Biomedical Engineering
• Molecular Diagnostics
• Nanotechnology

Background:

• Glioma, a prevalent and aggressive primary central nervous system tumor, necessitates early diagnosis for improved patient outcomes.
• MicroRNAs (miRNAs), including miR-21 and miR-155, exhibit altered expression in gliomas, positioning them as potential early diagnostic biomarkers.
• Current diagnostic methods may lack the sensitivity and specificity required for timely glioma detection.

Purpose of the Study:

• To develop and validate a highly sensitive and specific fluorescence sensing platform for the simultaneous detection of miR-21 and miR-155.
• To establish an "AND gate" logic system for enhanced diagnostic accuracy, minimizing false positives.
• To evaluate the platform's performance in complex biological samples like serum for potential clinical application.

Main Methods:

• An "AND gate" logic fluorescence sensing platform was engineered utilizing upconversion nanoparticle (UCNP) and mesoporous silica (mSiO2) components.
• The platform was optimized for the simultaneous and specific measurement of dual miRNA targets, miR-21 and miR-155.
• Performance metrics including limit of detection (LOD), linear range, specificity, and recovery in serum samples were rigorously assessed.

Main Results:

• The sensing platform achieved low limits of detection for miR-21 (0.181 nM) and miR-155 (0.185 nM) within linear ranges of 0.5–10 nM.
• The "AND gate" logic ensured significant fluorescence signals only upon the presence of both target miRNAs, demonstrating high specificity against single or interfering miRNAs.
• Accurate detection in serum samples was confirmed with high spiked recoveries (92%–100.69% for miR-21, 96.78%–100.66% for miR-155) and low relative standard deviations (<7%).

Conclusions:

• The developed UCNP-mSiO2 based "AND gate" fluorescence sensing platform offers a sensitive, specific, and stable method for dual miRNA detection.
• The platform's ease of operation, lack of enzyme amplification, and low background signal make it suitable for complex biological matrices.
• This technology presents a promising advancement for the early identification, progression monitoring, and precise diagnosis of gliomas.